Effects of DDIT4 in Methamphetamine-Induced Autophagy and Apoptosis in Dopaminergic Neurons

Molecular Neurobiology

Volumn 54, Issue 3, 2017, Pages 1642-1660

  Li, Bing ^a   Chen, Rui ^a,d   Chen, Ling ^a   Qiu, Pingming ^a   Ai, Xiuyun ^a   Huang, Enping ^a   Huang, Weiye ^a   Chen, Chuanxiang ^a   Liu, Chao ^b   Lin, Zhoumeng ^c   Xie, Wei Bing ^a   Wang, Huijun ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b Guangzhou Forensic Science Institute   (China)

^c KANSAS STATE UNIVERSITY   (United States)

^d GUANGDONG MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Autophagy; DNA damage inducible transcript 4 (DDIT4); Dopamine; Methamphetamine; Neurotoxicity

Indexed keywords

3 METHYLADENINE; CASPASE 3; METHAMPHETAMINE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN DDIT4; RAPAMYCIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; DDIT4 PROTEIN, HUMAN;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUTOPHAGY; CATECHOLAMINE NERVE CELL; CONTROLLED STUDY; CORPUS STRIATUM; DDIT4 GENE; DOPAMINERGIC NERVE CELL; EXPOSURE; GENE EXPRESSION; GENE TARGETING; HIPPOCAMPUS; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; NEUROTOXICITY; NONHUMAN; PREFRONTAL CORTEX; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; RAT; ANIMAL; BIOSYNTHESIS; DOSE RESPONSE; DRUG EFFECTS; METABOLISM; PATHOLOGY; PC12 CELL LINE; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; APOPTOSIS; AUTOPHAGY; DOPAMINERGIC NEURONS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MALE; METHAMPHETAMINE; PC12 CELLS; RATS; RATS, SPRAGUE-DAWLEY; TRANSCRIPTION FACTORS;

EID: 84956746879     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-015-9637-9     Document Type: Article

References (53)

1. Rawson R, Condon T (2007) Why do we need an addiction supplement focused on methamphetamine? Addiction 102:1–4. doi:10.1111/j.1360-0443.2006.01781.x
2. Larsen KE, Fon EA, Hastings TG, Edwards RH, Sulzer D (2002) Methamphetamine-induced degeneration of dopaminergic neurons involves autophagy and upregulation of dopamine synthesis. J Neurosci 22(20):8951–8960
3. Mark KA, Soghomonian JJ, Yamamoto BK (2004) High-dose methamphetamine acutely activates the striatonigral pathway to increase striatal glutamate and mediate long-term dopamine toxicity. J Neurosci 24(50):11449–11456. doi:10.1523/JNEUROSCI.3597-04.2004
4. Krasnova I, Cadet J (2009) Methamphetamine toxicity and messengers of death. Brain Res Rev 60(2):379–407. doi:10.1016/j.brainresrev.2009.03.002
5. Fumagalli F, Gainetdinov RR, Valenzano KJ, Caron MG (1998) Role of dopamine transporter in methamphetamine-induced neurotoxicity: evidence from mice lacking the transporter. J Neurosci 18(13):4861–4869
6. Volkow ND, Chang L, Wang GJ, Fowler JS, Franceschi D, Sedler M, Gatley SJ, Miller E et al (2001) Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence. J Neurosci 21(23):9414–9418
7. Qiao D, Xu J, Le C, Huang E, Liu C, Qiu P, Lin Z, Xie W et al (2014) Insulin-like growth factor binding protein 5 (IGFBP5) mediates methamphetamine-induced dopaminergic neuron apoptosis. Toxicol Lett 230(3):444–453. doi:10.1016/j.toxlet.2014.08.010
8. Huang W, Xie WB, Qiao D, Qiu P, Huang E, Li B, Chen C, Liu C et al (2015) Caspase-11 plays an essential role in methamphetamine-induced dopaminergic neuron apoptosis. Toxicol Sci 145(1):68–79. doi:10.1093/toxsci/kfv014
9. Nopparat C, Porter JE, Ebadi M, Govitrapong P (2010) The mechanism for the neuroprotective effect of melatonin against methamphetamine-induced autophagy. J Pineal Res 49(4):382–389. doi:10.1111/j.1600-079X.2010.00805.x
10. Kongsuphol P, Mukda S, Nopparat C, Villarroel A, Govitrapong P (2009) Melatonin attenuates methamphetamine-induced deactivation of the mammalian target of rapamycin signaling to induce autophagy in SK-N-SH cells. J Pineal Res 46(2):199–206. doi:10.1111/j.1600-079X.2008.00648.x
11. Isidoro C, Biagioni F, Giorgi FS, Fulceri F, Paparelli A, Fornai F (2009) The role of autophagy on the survival of dopamine neurons. Curr Top Med Chem 9(10):869–879
12. Lenzi P, Marongiu R, Falleni A, Gelmetti V, Busceti CL, Michiorri S, Valente EM, Fornai F (2012) A subcellular analysis of genetic modulation of PINK1 on mitochondrial alterations, autophagy and cell death. Arch Ital Biol 150(2–3):194–217. doi:10.4449/aib.v150i2/3.1417
13. Brugarolas J, Lei K, Hurley R, Manning B, Reiling J, Hafen E, Witter L, Ellisen L et al (2004) Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex. Genes Dev 18(23):2893–2904. doi:10.1101/gad.1256804
14. Tang Y, Pacary E, Freret T, Divoux D, Petit E, Schumann-Bard P, Bernaudin M (2006) Effect of hypoxic preconditioning on brain genomic response before and following ischemia in the adult mouse: identification of potential neuroprotective candidates for stroke. Neurobiol Dis 21(1):18–28. doi:10.1016/j.nbd.2005.06.002
15. Shoshani T, Faerman A, Mett I, Zelin E, Tenne T, Gorodin S, Moshel Y, Elbaz S et al (2002) Identification of a novel hypoxia-inducible factor 1-responsive gene, RTP801, involved in apoptosis. Mol Cell Biol 22(7):2283–2293. doi:10.1128/MCB.22.7.2283-2293.2002
16. Ellisen L (2005) Growth control under stress—mTOR regulation through the REDD1-TSC pathway. Cell Cycle 4(11):1500–1502
17. Guertin D, Sabatini D (2005) An expanding role for mTOR in cancer. Trends Mol Med 11(8):353–361. doi:10.1016/j.molmed.2005.06.007
18. Moore N, Azarova A, Bhatnagar N, Ross K, Drake L, Frumm S, Liu Q, Christie A et al (2014) Molecular rationale for the use of PI3K/AKT/mTOR pathway inhibitors in combination with crizotinib in ALK-mutated neuroblastoma. Oncotarget 5(18):8737–8749
19. Ravikumar B, Sarkar S, Davies J, Futter M, Garcia-Arencibia M, Green-Thompson Z, Jimenez-Sanchez M, Korolchuk V et al (2010) Regulation of mammalian autophagy in physiology and pathophysiology. Physiol Rev 90(4):1383–1435. doi:10.1152/physrev.00030.2009
20. Levine B, Yuan J (2005) Autophagy in cell death: an innocent convict? J Clin Investig 115(10):2679–2688. doi:10.1172/JCI26390|10.1172/JC126390
21. Ichimura Y, Kirisako T, Takao T, Satomi Y, Shimonishi Y, Ishihara N, Mizushima N, Tanida I et al (2000) A ubiquitin-like system mediates protein lipidation. Nature 408(6811):488–492
22. Tanida I, Ueno T, Kominami E (2004) LC3 conjugation system in mammalian autophagy. Int J Biochem Cell Biol 36(12):2503–2518. doi:10.1016/j.biocel.2004.05.009
23. Korecka JA, van Kesteren RE, Blaas E, Spitzer SO, Kamstra JH, Smit AB, Swaab DF, Verhaagen J et al (2013) Phenotypic characterization of retinoic acid differentiated SH-SY5Y cells by transcriptional profiling. PLoS One 8(5):e63862. doi:10.1371/journal.pone.0063862
24. Greene LA, Tischler AS (1976) Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc Natl Acad Sci U S A 73(7):2424–2428
25. Lin Z, Dodd CA, Filipov NM (2013) Short-term atrazine exposure causes behavioral deficits and disrupts monoaminergic systems in male C57BL/6 mice. Neurotoxicol Teratol 39:26–35. doi:10.1016/j.ntt.2013.06.002
26. Kobeissy FH, Mitzelfelt JD, Fishman I, Morgan D, Gaskins R, Zhang Z, Gold MS, Wang KK (2012) Methods in drug abuse models: comparison of different models of methamphetamine paradigms. Methods Mol Biol 829:269–278. doi:10.1007/978-1-61779-458-2_17
27. Danaceau JP, Deering CE, Day JE, Smeal SJ, Johnson-Davis KL, Fleckenstein AE, Wilkins DG (2007) Persistence of tolerance to methamphetamine-induced monoamine deficits. Eur J Pharmacol 559(1):46–54. doi:10.1016/j.ejphar.2006.11.045
28. Tokunaga I, Ishigami A, Kubo S, Gotohda T, Kitamura O (2008) The peroxidative DNA damage and apoptosis in methamphetamine-treated rat brain. J Med Investig 55(3–4):241–245, Japan
29. Chen C, Qincao L, Xu J, Du S, Huang E, Liu C, Lin Z, Xie WB et al (2016) Role of PUMA in methamphetamine-induced neuronal apoptosis. Toxicol Lett 240(1):149–160. doi:10.1016/j.toxlet.2015.10.020
30. Wang SF, Yen JC, Yin PH, Chi CW, Lee HC (2008) Involvement of oxidative stress-activated JNK signaling in the methamphetamine-induced cell death of human SH-SY5Y cells. Toxicology 246(2–3):234–241. doi:10.1016/j.tox.2008.01.020
31. Wu CW, Ping YH, Yen JC, Chang CY, Wang SF, Yeh CL, Chi CW, Lee HC (2007) Enhanced oxidative stress and aberrant mitochondrial biogenesis in human neuroblastoma SH-SY5Y cells during methamphetamine induced apoptosis. Toxicol Appl Pharmacol 220(3):243–251. doi:10.1016/j.taap.2007.01.011
32. Melega WP, Cho AK, Harvey D, Lacan G (2007) Methamphetamine blood concentrations in human abusers: application to pharmacokinetic modeling. Synapse 61(4):216–220. doi:10.1002/syn.20365
33. Winek CL, Wahba WW, Winek CL Jr, Balzer TW (2001) Drug and chemical blood-level data 2001. Forensic Sci Int 122(2–3):107–123
34. Schepers RJ, Oyler JM, Joseph RE Jr, Cone EJ, Moolchan ET, Huestis MA (2003) Methamphetamine and amphetamine pharmacokinetics in oral fluid and plasma after controlled oral methamphetamine administration to human volunteers. Clin Chem 49(1):121–132
35. Lu Y, Sun XD, Hou FQ, Bi LL, Yin DM, Liu F, Chen YJ, Bean JC et al (2014) Maintenance of GABAergic activity by neuregulin 1-ErbB4 in amygdala for fear memory. Neuron 84(4):835–846. doi:10.1016/j.neuron.2014.09.029
36. Su J, Zhang T, Wang K, Zhu T, Li X (2014) Autophagy activation contributes to the neuroprotection of remote ischemic perconditioning against focal cerebral ischemia in rats. Neurochem Res 39(11):2068–2077. doi:10.1007/s11064-014-1396-x
37. Meijer AJ, Codogno P (2006) Signalling and autophagy regulation in health, aging and disease. Mol Asp Med 27(5-6):411–425. doi:10.1016/j.mam.2006.08.002, England
38. Sinha I, Allen J, Pinto J, Sinha R (2014) Methylseleninic acid elevates REDD1 and inhibits prostate cancer cell growth despite AKT activation and mTOR dysregulation in hypoxia. Cancer Med 3(2):252–264. doi:10.1002/cam4.198
39. Jayanthi S, Deng XL, Noailles PAH, Ladenheim B, Cadet JL (2004) Methamphetamine induces neuronal apoptosis via cross-talks between endoplasmic reticulum and mitochondria-dependent death cascades. FASEB J 18(2):238–251. doi:10.1096/fj.03-0295com
40. Gu Y, Kaufman J, Bernal L, Torre C, Matulis S, Harvey R, Chen J, Sun S et al (2014) MLN4924, an NAE inhibitor, suppresses AKT and mTOR signaling via upregulation of REDD1 in human myeloma cells. Blood 123(21):3269–3276. doi:10.1182/blood-2013-08-521914
41. Wolff N, McKay R, Brugarolas J (2014) REDD1/DDIT4-independent mTORC1 inhibition and apoptosis by glucocorticoids in thymocytes. Mol Cancer Res 12(6):867–877. doi:10.1158/1541-7786.MCR-13-0625
42. Mariño G, Niso-Santano M, Baehrecke EH, Kroemer G (2014) Self-consumption: the interplay of autophagy and apoptosis. Nat Rev Mol Cell Biol 15(2):81–94. doi:10.1038/nrm3735
43. Pitaksalee R, Sanvarinda Y, Sinchai T, Sanvarinda P, Thampithak A, Jantaratnotai N, Jariyawat S, Tuchinda P et al (2015) Autophagy inhibition by caffeine increases toxicity of methamphetamine in SH-SY5Y neuroblastoma cell line. Neurotox Res. doi:10.1007/s12640-014-9513-9
44. Ma J, Wan J, Meng J, Banerjee S, Ramakrishnan S, Roy S (2014) Methamphetamine induces autophagy as a pro-survival response against apoptotic endothelial cell death through the kappa opioid receptor. Cell Death Dis 5:e1099. doi:10.1038/cddis.2014.64
45. Chandramani Shivalingappa P, Jin H, Anantharam V, Kanthasamy A, Kanthasamy A (2012) N-Acetyl cysteine protects against methamphetamine-induced dopaminergic neurodegeneration via modulation of redox status and autophagy in dopaminergic cells. Parkinsons Dis 2012:424285. doi:10.1155/2012/424285
46. Fornai F, Lenzi P, Gesi M, Soldani P, Ferrucci M, Lazzeri G, Capobianco L, Battaglia G et al (2004) Methamphetamine produces neuronal inclusions in the nigrostriatal system and in PC12 cells. J Neurochem 88(1):114–123
47. Castino R, Lazzeri G, Lenzi P, Bellio N, Follo C, Ferrucci M, Fornai F, Isidoro C (2008) Suppression of autophagy precipitates neuronal cell death following low doses of methamphetamine. J Neurochem 106(3):1426–1439. doi:10.1111/j.1471-4159.2008.05488.x
48. Shen S, Kepp O, Kroemer G (2012) The end of autophagic cell death? Autophagy 8(1):1–3. doi:10.4161/auto.8.1.16618
49. Kroemer G, Levine B (2008) Autophagic cell death: the story of a misnomer. Nat Rev Mol Cell Biol 9(12):1004–1010. doi:10.1038/nrm2529
50. Lipton JO, Sahin M (2014) The neurology of mTOR. Neuron 84(2):275–291. doi:10.1016/j.neuron.2014.09.034
51. Malagelada C, Ryu EJ, Biswas SC, Jackson-Lewis V, Greene LA (2006) RTP801 is elevated in Parkinson brain substantia nigral neurons and mediates death in cellular models of Parkinson’s disease by a mechanism involving mammalian target of rapamycin inactivation. J Neurosci 26(39):9996–10005. doi:10.1523/JNEUROSCI.3292-06.2006
52. Malagelada C, Jin ZH, Greene LA (2008) RTP801 is induced in Parkinson’s disease and mediates neuron death by inhibiting Akt phosphorylation/activation. J Neurosci 28(53):14363–14371. doi:10.1523/JNEUROSCI.3928-08.2008
53. Christine CW, Garwood ER, Schrock LE, Austin DE, McCulloch CE (2010) Parkinsonism in patients with a history of amphetamine exposure. Mov Disord 25(2):228–231. doi:10.1002/mds.22915